Clinical Advisors – Overactive Bladder

Professor Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals and visiting professor at Sheffield Hallam University. He has a particular interest in functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms. He is Past Director of the European School of Urology and an Adjunct Secretary General to the European Association of Urology. Professor Chapple trained at the Middlesex Hospital where he subsequently completed his doctorate thesis on pharmacological control mechanisms in the lower urinary tract. His sub-specialist training was at the Middlesex Hospital and Institute of Urology in London and he provides a tertiary service in lower urinary tract reconstructive surgery. He is an active member of many international urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Royal Society of Medicine, the British Medical Association and the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He is editor of the journal Neurourology and Urodynamics.

Michael B Chancellor, MD is Professor of Urology and Director of the Neurourology and Urinary Incontinence Programmes at the University of Pittsburgh Medicine Center (UPMC). He earned his medical degree from the Medical College of Wisconsin, completing his urology residency at the University of Michigan and a fellowship in neurourology and female urology at Columbia University. Before joining UPMC, Dr. Chancellor was an associate professor of urology at Thomas Jefferson University in Philadelphia. His clinical interests include neurourology, urinary incontinence, and reconstructive surgery of the urinary tract. He is Director of the Mentored Clinical Scientist Development Programme in Urology and a researcher training programme sponsored by the National Institutes of Health (NIH). He is also the director of NIH-funded clinical trials for women, focusing on stress urinary incontinence and pelvic prolapse. Dr.Chancellor is board certified by the American Board of Urology.

Dr Karl-Erik Andersson received his medical degree from the University of Lund in 1968, where he subsequently worked as a lecturer in clinical pharmacology. He completed his PhD at the Department of Pharmacology, Lund University, in 1973. In 1975 he obtained a Swedish specialist degree in Internal Medicine and was appointed Professor of Clinical Pharmacology at the University of Odense, Denmark. From 1976 to 1978 he had the same position at the University of Aarhus, Denmark. From 1978-2006 he was Professor and Chairman of the Department of Clinical Pharmacology, University of Lund, Lund, Sweden. He has been visiting professor at the Department of Obstetrics and Gynaecology, University of Toronto (1983-1985) and at the Department of Urology, University of Virginia, Charlottesville, USA (1997-1998). From 1993 to 2000 Dr Andersson was Research Dean of the Medical Faculty at the University of Lund. He is a member of many international societies including the American Urological Association, the European Association of Urology, and the International Society for Sexual and Impotence Research. He also serves on the Editorial Boards of several journals including Urology, European Urology, Neurourology and Urodynamics, International Journal of Impotence Research, and British Journal of Pharmacology.

Professor Dirk de Ridder holds a chair in the Department of Urology, University Hospital Gasthuisberg, Leuven, Belgium. His research interests lie in the area of overactive bladder and transient receptor potential (TRP) channel involvement in the regulation of bladder function. Professor de Ridder has been involved in several clinical studies with new drugs for bladder disorders.